Smart scans and DNA tests aim to match liver cancer patients with best treatments
NCT ID NCT04597710
First seen Jan 06, 2026 · Last updated May 15, 2026 · Updated 16 times
Summary
This study looks at whether combining detailed MRI scans, whole genome sequencing, and digital pathology can help doctors choose the best treatment for people with liver cancer. Researchers will study 200 adults who are scheduled for liver surgery. The goal is to see if these advanced tests provide useful information that could change the treatment plan, such as selecting targeted therapies or avoiding unnecessary surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Basingstoke and North Hampshire Hospital
Basingstoke, Hampshire, RG249NA, United Kingdom
Conditions
Explore the condition pages connected to this study.